A Phase 1 Dose Escalation Study of IPI-493

Clinical trial NCT00724425 · TERMINATED

Trial details

NCT number: NCT00724425
Sponsor: Infinity Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2008-07-01
Primary completion: 2011-07-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.